MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

LTC technical analysis shows Litecoin testing resistance at $117. A breakout could lead to 14% gains, with $100 as a key ...

Key Points MEI Pharma announced a $100 million private placement to accumulate Litecoin, as well as the addition of Charlie ...

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

Ozak AI is at stage four of its presale, and this is a very affordable point of entry at a relatively low price of only 0.005 ...

After months of behind-the-scenes action, Litecoin, Bitcoin’s little sister, might be ready to make a major splash. Litecoin ...

Tracing the weekly technical analysis, Litecoin has broken through the 55-EMA and 200-EMA—two indicators often used by medium ...

Litecoin price prediction has become a hot topic after LTC rallied past the $100 resistance, closing at $104.95 on July 18. This push came alongside news of MEI Pharma’s $100 million Litecoin treasury ...

Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

Litecoin nears $110 resistance amid bullish signals: whale accumulation, exchange outflows, and a double bottom pattern ...

Litecoin Jumps 10% in 24 hours, reaching $105.88. The weekly gain hits 9.1% amid growing market optimism and strong trading ...

A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...